Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Guggenheim Upgrades Teladoc Health to Neutral

Guggenheim Upgrades Teladoc Health to Neutral

Guggenheim analyst Sandy Draper upgrades Teladoc Health (NYSE:TDOC) from Sell to Neutral.

October 24, 2022

1 minute read

Guggenheim analyst Sandy Draper upgrades Teladoc Health (NYSE:TDOC) from Sell to Neutral.

Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights

June 20, 9:01 AM

6 analysts have shared their evaluations of ADMA Biologics (NASDAQ:ADMA) during the recent three months, expressing a mix…

April 10, 2:01 PM

In the preceding three months, 7 analysts have released ratings for Murphy Oil (NYSE:MUR), presenting a wide array…

April 10, 2:04 PM

Truist Securities downgraded Arthur J. Gallagher & Co. to Hold and lowered price target to $255 due to negative industry data and slowing growth.

August 31, 1:29 PM

Wedbush analyst Moshe Katri reiterated Visa Inc (NYSE: V) with an Outperform and a